keine Finanzberatung
🔍 Search…
📊 Portfolio ← All

BSX · Boston Scientific Corp.

S&P 500 #189 · NYSE

Risiko 6/10 · Elevated — guidance cut · $46.06 ▲ 1.21%

Kennzahlen

  • Price $46.06
  • Market cap $68.5B
  • P/E (ttm) 19.27
  • Div yield none
  • 52-wk range $42.20 – $109.50
  • Index rank #189 / —

Wichtigste Risiken

  • Watchman Device Guidance Cut (Medical device investors) — EXTREME
  • Near 52-week low (All shareholders) — HIGH
  • Regulatory/FDA risk on new products (Growth investors) — MED
  • High acquisition integration costs (Long-term holders) — MED

Fazit

Global medical device leader now trading near 52-week lows after guidance reduction tied to its Watchman heart-closure device.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.